Business Context and Reporting Period
This Form 8-K filing by ADVENTRX Pharmaceuticals, Inc. (not Savara Inc.) reports on the annual meeting of stockholders held on June 30, 2010. The report details the final voting results for director elections and the ratification of the independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes and Voting Results
Director Elections
Stockholders elected all five nominees to the Board of Directors. The voting breakdown was as follows:
| Nominee | For | Against | Abstain | Broker Non-Votes |
|---|---|---|---|---|
| Michael M. Goldberg | 1,413,058 | 157,645 | 20,924 | 7,853,454 |
| Odysseas D. Kostas | 1,411,768 | 159,953 | 19,907 | 7,853,453 |
| Jack Lief | 1,409,903 | 161,308 | 20,416 | 7,853,454 |
| Mark J. Pykett | 1,353,926 | 216,758 | 20,944 | 7,853,453 |
| Eric K. Rowinsky | 1,411,289 | 161,177 | 19,161 | 7,853,454 |
Accounting Firm Ratification
Stockholders ratified the appointment of J.H. Cohn LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2010.
- For: 8,945,881
- Against: 410,635
- Abstain: 88,565
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the reporting of voting outcomes.
Investor Verification Checklist
- Verify the company name is ADVENTRX Pharmaceuticals, Inc., as the input metadata referenced Savara Inc.
- Confirm the high volume of broker non-votes (approx. 7.85 million) relative to the "For" votes (approx. 1.4 million) in the director elections.
- Review the full proxy statement for context on the director nominees and the rationale for the accounting firm selection.
- Check subsequent filings for the actual financial performance for the fiscal year ending December 31, 2010.